The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages
Abstract
Immune system dysregulation is well-recognized in autism and thought to be part of the etiology of this disorder. The endocannabinoid system is a key regulator of the immune system via the cannabinoid receptor type 2 (CB2R) which is highly expressed on macrophages and microglial cells. We have previously published significant differences in peripheral blood mononuclear cell CB2R gene expression in the autism population.
Background
The use of the Gc protein-derived Macrophage Activating Factor (GcMAF) has been proposed as a potential immunotherapy for autism. GcMAF is a naturally occurring protein in the human body that activates macrophages — the immune system's first line of defense. This study examines the in vitro effects of GcMAF on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages.
The Endocannabinoid System and Immunity
The endocannabinoid system (ECS) is a complex cell-signaling system that plays a crucial role in regulating a wide range of functions and processes, including sleep, mood, appetite, memory, reproduction, and fertility. The ECS exists and is active in your body even if you don't use cannabis. The ECS involves three core components: endocannabinoids, receptors, and enzymes. CB2R is particularly relevant to immune function and is highly expressed on macrophages.
GcMAF and Macrophage Activation
GcMAF (Gc protein-derived Macrophage Activating Factor) is a naturally occurring protein in the human body that activates macrophages. Macrophages are white blood cells that engulf and digest cellular debris, foreign substances, microbes, cancer cells, and anything else that does not have the type of proteins specific to healthy body cells on its surface. GcMAF has been shown to activate macrophages in vitro and in vivo, and has been proposed as a potential immunotherapy for a variety of conditions.
Bravo Probiotic Yogurt and GcMAF Production
Bravo Probiotic Yogurt has been uniquely formulated to stimulate the natural production of GcMAF in the gut. The 300+ probiotic strains in Bravo work synergistically to create the optimal conditions for GcMAF production. Unlike synthetic GcMAF preparations, the GcMAF produced through Bravo consumption is entirely natural and is produced within the body's own systems, making it a safe and effective approach to immune support.
Conclusions
The results of this study suggest that GcMAF has significant effects on the endocannabinoid system in autism-derived macrophages, including changes in transcriptomics, receptor formation, and cell activity. These findings support the potential therapeutic role of GcMAF in autism and other conditions characterized by immune dysregulation. Further research is needed to fully understand the mechanisms involved and to develop optimal therapeutic protocols.
Tags
Related Articles
Try Bravo Probiotic
Experience the science firsthand. 300+ probiotic strains, natural GcMAF production, Swiss-formulated.
Shop Now